Ossica (Ibandronate Sodium Hydrate)

Ibandronate Sodium Hydrate, the active ingredient in Ossica, is a bisphosphonate presented as a oral tablet for osteoporosis treatment in post‑menopausal women and men at risk of fracture. It is formulated to improve bone mineral density and reduce skeletal related events.

GNH USA supplies Ossica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ossica is a bisphosphonate that acts on bone metabolism to treat conditions characterised by increased bone resorption. - Post‑menopausal osteoporosis: helps to increase the density of spine and hip bone, lowering the risk of fracture. - Male osteoporosis: supports bone‑strengthening in men with low bone mass. - Glucose‑dependent insulin insulin resistance ? This does not appear to ...

Common ...

...

{"...":null}